Bristol Myers Squibb joins Rare Access Action Project coalition
AI Summary- Bristol Myers Squibb joined the Rare Access Action Project as its newest member.
- BMS focuses on oncology, hematology, immunology, cardiovascular disease and neuroscience.
- RAAP brings patients, advocates, policymakers and innovators together on rare disease access issues.